Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults4 Nov 2026

Shelter Pharma Ltd

Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing obligations and Disclosure requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Saturday, 07th November, 2026, at corporate office of the company at 5TH Floor, 501 SAKAR ....

Shelter Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 to consider and approve the Un-audited Financial Results for the Half year ended on September 30, 2026, along with Limited Review report.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Sancode Technologies Ltd

Sancode Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial Results of the company for the half year ended on September 30, 2026.

Sancode Technologies Ltd has scheduled a Board Meeting on November 14, 2026, to consider and approve the Unaudited Financial Results for the half year ended September 30, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

MRP Agro Ltd

MRP Agro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve MRP Agro Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on 14/11/2026 ,inter alia, to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter and Half year ended September 30, ....

MRP Agro Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter and Half year ended September 30, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults4 Nov 2026

Amanta Healthcare Limited

Press Release

Amanta Healthcare Limited has announced its Q2 & H1FY27 results, with revenue growing 17% YoY to ₹83.13 crore and PAT margin expanding to 5.85%. The company has also commissioned SteriPort Line 3, raising capacity by 75%, and is targeting a further expansion in Q1FY28.

Read more →📎 1 attachment
BSECompany UpdateResults4 Nov 2026

Camlin Fine Sciences Ltd

Newspaper Publication - UFR for the quarter and half year ended September 30, 2026.

Camlin Fine Sciences Ltd has published its unaudited financial results for the quarter and half year ended September 30, 2026, along with details of its recent equity share offer. The company has allocated shares to various categories of bidders, including institutional investors, retail individual bidders, and non-institutional investors.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults4 Nov 2026

Camlin Fine Sciences Limited

Copy of Newspaper Publication

Camlin Fine Sciences Limited has informed the Exchange about the publication of un-audited financial results for the quarter and half year ended September 30, 2026, in newspapers. The company also announced the details of its recent share buyback offer.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults4 Nov 2026

Jyoti Structures Limited

Copy of Newspaper Publication

Jyoti Structures Limited has informed the Exchange about Copy of Newspaper Publication with regards to Standalone & Consolidated Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Nov 2026

Kirloskar Brothers Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Kirloskar Brothers Limited's Q2 and H1FY27 earnings conference call transcript has been uploaded on the stock exchanges and the company's website. The company reported a 24% year-on-year growth in consolidated revenues, reaching Rs.12,767 million for the quarter and Rs.23,816 million for H1. EBITDA for the quarter grew by 16% to Rs.1,432 million, and for H1, it grew by 9% to Rs.2,738 million. The company also recorded healthy order inflows across both domestic and international markets, with a consolidated order intake growing by 68% year-on-year to Rs.20,472 million.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Deccan Cements Ltd-$

Deccan Cements Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated financial results for the quarter ended 30th September 2026

Deccan Cements Ltd has scheduled a Board Meeting on 12th November 2026 to consider and approve the Unaudited Standalone and Consolidated financial results for the quarter ended 30th September 2026.

Read more →📎 1 attachment
NSEUpdates▲ PositiveResults4 Nov 2026

Xpro India Limited

Updates

Xpro India Limited has informed the Exchange regarding 'Investor Presentation' for Q2-FY27/H1FY27, showcasing improved performance with higher volumes, better product mix, and growing contribution of expanded capacity. The company has strengthened its market position in domestic and export markets, with a net worth of Rs. 729.4 crores and a RoCE of 15.7%. The presentation highlights the company's disciplined growth, with a focus on ramping up new capacity, broadening customer approvals, and improving volumes and margins.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Nov 2026

Shree Rajeshwaranand Paper Mills Ltd

Shree Rajeshwaranand Paper Mills Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results of the Company for the second Quarter and half year ended September 30, 2026

Shree Rajeshwaranand Paper Mills Ltd has scheduled a Board Meeting on 07/11/2026 to consider and approve Un-Audited Financial Results for the second Quarter and half year ended September 30, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Nov 2026

Kirloskar Brothers Ltd-$

Please find enclosed intimation under Regulation 30 of the SEBI Listing Regulations, 2015 pertaining to transcript of Analyst Meet.

Kirloskar Brothers Ltd reported 24% YoY growth in consolidated revenues for Q2FY27, reaching Rs.12,767 million, and 19% YoY growth for H1FY27, reaching Rs.23,816 million. EBITDA for Q2FY27 grew by 16% YoY, reaching Rs.1,432 million, and for H1FY27 grew by 9%, reaching Rs.2,738 million.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults4 Nov 2026

Neuland Laboratories Limited

Copy of Newspaper Publication

Neuland Laboratories Limited has informed the Exchange about publishing copies of newspaper advertisement regarding financial results for the quarter and half year ended September 30, 2026, as per Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Read more →📎 1 attachment
BSECompany UpdateResults4 Nov 2026

Neuland Laboratories Ltd

Copy of Newspaper Publication

Neuland Laboratories Ltd has published newspaper advertisements regarding its financial results for the quarter and half year ended September 30, 2026, as per Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Nov 2026

Xpro India Ltd

Investor Presentation

Xpro India Ltd has reported its Q2-FY27 and H1FY27 financial results, showing a 47.4% year-over-year increase in revenue and a 53.5% year-over-year increase in EBITDA. The company's net worth stands at Rs. 729.4 crores, and its RoCE and RoE are 15.7% and 11.1%, respectively.

Read more →📎 1 attachment
← PreviousPage 792 of 4428Next →